PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
NEW YORK--(BUSINESS WIRE)--$LUCD--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid Diagnostics...